PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-121

  1. 1,271 Posts.
    lightbulb Created with Sketch. 255
    I think we need to wait for the MPS results & confirmation of the dose by the FDA that's when there would be partnerships IMO
    The problem is that's very soon & now the deals are by June 2024 I thought they said Q1 2024 before but I might be wrong.
    If they don't happen soon I can't see why things suddenly align in June
    Last edited by Weazel: 01/02/24
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.